Trial Profile
The effect of eszopiclone 3 mg compared to placebo on daytime function in subjects with insomnia related to rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Sumitomo Pharma America
- 12 Oct 2006 New trial record.